Current Drug Targets - CNS & Neurological Disorders

Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) ...read more

  • ISSN (Print): 1568-007X
  • ISSN (Online): 1568-007X
  • Volume: 4
  • Issues: 6, 2005
2.628
Current Drug Targets - CNS & Neurological Disorders
Review Article
Reactive Oxygen Species (ROS): Key Components in Cancer Therapies

Pp: 215-222

Volume: 22 Issues: 2

Authors:Biswa Mohan Sahoo*, Bimal Krishna Banik, Preetismita Borah and Adya Jain

DOI: 10.2174/1871520614666140624110458

Published on:September 12, 2023

Add to Wishlist Purchase PDF
Review Article
Reactive Oxygen Species (ROS): Key Components in Cancer Therapies

Pp: 215-222

Volume: 22 Issues: 2

Authors:Biswa Mohan Sahoo*, Bimal Krishna Banik, Preetismita Borah and Adya Jain

DOI: 10.2174/1871520614666140624110458

Published on:September 12, 2023

Add to Wishlist Purchase PDF
Review Article
Reactive Oxygen Species (ROS): Key Components in Cancer Therapies

Pp: 215-222

Volume: 22 Issues: 2

Authors:Biswa Mohan Sahoo*, Bimal Krishna Banik, Preetismita Borah and Adya Jain

DOI: 10.2174/1871520614666140624110458

Published on:September 12, 2023

Add to Wishlist Purchase PDF
Review Article
Reactive Oxygen Species (ROS): Key Components in Cancer Therapies

Pp: 215-222

Volume: 22 Issues: 2

Authors:Biswa Mohan Sahoo*, Bimal Krishna Banik, Preetismita Borah and Adya Jain

DOI: 10.2174/1871520614666140624110458

Published on:September 12, 2023

Add to Wishlist Purchase PDF

content are coming soon...!

content are coming soon...!

content are coming soon...!

Share Your Research

Join our call for papers and contribute to the ever-evolving world of science.
Share your research with a global audience.

Calls for Papers

Special issues and article collections

Endorsement(s)

"This journal is the definitive source for the most meaningful and critical information available on CNS drug targets and progress both in industrial and academic based neurodegeneration research."

Rudolf E. Tanzi
Harvard Medical School, USA

Related Journals

Related Books